Main Industry
Biotechnology
Main Product/Service
Our pipeline is driven by our revolutionary research into immune response. Each product builds on our unique understanding of innate immunity and how this natural control can be used to destroy solid tumors or calm autoimmune inflammation. ASD141, our fir
Founded Year
2023
Unified Business No.
83000625
Status
Active
Number of Employees
0
Total Paid-in
Capital
242,420,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Ascendo Biotechnology is a clinical-stage pharmaceutical company founded in 2019. We leverage cutting-edge research in the field of dysregulated immune function to develop novel immunotherapy solutions for cancer and autoimmune diseases.
